1Arroyo V, Gines P, Gerbes A, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International aseites clubs[J]. Hepatology, 1996,23: 164 - 173.
2Arroyo V, Fernandez J, Gines P. Pathogenesis and treatment of hepatorenal syndrome[J]. Sere in Liver Dis, 2008,28 (1) : 81 - 95.
3Fabrizi F, Dixit V, Martin P. Meta - analysis terlipress in therapy for the hepatorenal syndrome[J]. Aliment Pharmacol Ther,2006,24(6) :935 - 944.
1Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club [J ]. Hepatology, 1996, 23 ( 1 ) : 164 -176.
2Hadengue A. Somatostatin or Octreotide in Acute Variceal Bleeding[J ]. Digestion, 1999,60 (Suppl. 2) : 31 - 41.
3Sabat M, Guamer C, Soriano G, et al. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites[J]. Dig Dis Sci,1998,43(10):2184 - 2189.
4Angeli P, Volpin R, Gerunda G, et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide[l]. Hepatology, 1999,29(6): 1690-1697.
5Mountokalakis T, Kailivretakis N, Mayopoulou - Symvoulidou D,et al. Enhancemcnt of renal function by a long - acting somatostatin analogue in patients with decompensated cirrhosis [J ].Nephroi Dial Transplant, 1988,3 (5) : 604 - 607.
6Dumortier J, Lepretre J, Scalone O, et al. Successful treatment of hepatic hydrothorax with octreotide[J ]. Eur J Gastroenterol Hepatol, 2000, 12(7):817-820.
7Escorsell A, Bandi JC, Andreu V, et al. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension[J]. Gastroenterology, 2001, 120: 161- 169.
5Khunvirojpanich M, Wattanasirichaigoon S, Pradi- darcheep W. Expressional changes of carbamoyl phosphate synthetase and glutamine synthetase inthe liver of rat with thioacetamide-induced cirrho- sis. JMedAssoc Thai 2013; 96 Suppl 1:$71-$77 [PMID: 23724459].
6Sirinthornpunya S, Luangvichcharoen K. Effect of 4% gelofusine plus antibiotics on renal impairment and mortality in high-risk cirrhotic patients with spontaneous bacterial peritonitis. J Med Assoc Thai 2013; 96 Suppl 3:$77-$83 [PMID: 23682527].
